The Effect of I-131 Treatment on Complete Blood Count

Basit Öğe Kaydı
dc.contributor.authorSahutoglu, G.
dc.contributor.authorCetin, S. K.
dc.contributor.authorAtilgan, H. I.
dc.date.accessioned2024-09-18T20:59:26Z
dc.date.available2024-09-18T20:59:26Z
dc.date.issued2024
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractRadioactive iodine -131 (RAI) treatment may cause suppression in the bone marrow. In this study, hemoglobin levels, leukocyte, thrombocyte, and lymphocyte counts will be compared before total thyroidectomy and 6 months after RAI treatment. 97 patients (76 females, 21 males) with a diagnosis of well -differentiated thyroid cancer who had undergone total thyroidectomy and received 50-200 mCi RAI treatment were included in the study. Hemoglobin levels, leukocyte, thrombocyte, and lymphocyte counts of the patients in the last month before the treatment and in the sixth month after the treatment were compared retrospectively. When the whole patients were analyzed, hemoglobin levels, leukocyte, thrombocyte, and lymphocyte counts in pretreatment were statistically lower than after -treatment values. While hemoglobin levels of female patients were similar before and after treatment, lymphocyte, thrombocyte, and leukocyte counts were statistically lower before treatment. Hemoglobin levels, leukocyte,and thrombocyte counts were similar before and after treatment, while lymphocytes decreased significantly after RAI treatment. Thyroid cancer patients who received 50-200 mCi RAI treatment after total thyroidectomy, have bone marrow suppression but are still in normal mean value ranges. This mild bone marrow suppression is more prominent in female patients than in male patients. (c) 2024 Atom Indonesia. All rights reserveden_US
dc.identifier.doi10.55981/aij.2024.1381
dc.identifier.endpage70en_US
dc.identifier.issn0126-1568
dc.identifier.issn2356-5322
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85192825608en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage67en_US
dc.identifier.urihttps://doi.org/10.55981/aij.2024.1381
dc.identifier.urihttps://hdl.handle.net/20.500.12483/12574
dc.identifier.volume50en_US
dc.identifier.wosWOS:001228179200005en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherNatl Atomic Energy Agency Indonesiaen_US
dc.relation.ispartofAtom Indonesiaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectThyroid canceren_US
dc.subjectIodine-131en_US
dc.subjectHemoglobinen_US
dc.subjectLeukocyteen_US
dc.subjectThrombocyteen_US
dc.titleThe Effect of I-131 Treatment on Complete Blood Counten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu